Nancy C. Andrews
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nancy C. Andrews
Earlier roles on record: Board Member at Maze Therapeutics, Inc. (MAZE) until August 13, 2026. Maze Therapeutics, Inc. reported in an 8-K filed August 17, 2026 that Nancy C. Andrews resigned as Class III director, effective August 13, 2026.
“effective August 13, 2026, Nancy C. Andrews, M.D., Ph.D. resigned from her position as a Class III director (with a term expiring at the Company's 2028 annual meeting of stockholders), subject to and conditioned upon her immediate reappointment as a Class II director, and the Board accepted Dr. Andrews' resignation and immediately reappointed her as a Class II director with a term expiring at the Company's 2027 annual meeting of stockholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-01-01–2026-08-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.